
Deborah Crouch
Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 3725, 1819, 1632, 2899, 1804 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 914988
[patent_doc_number] => 07326824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Unactivated ungulate oocytes to produce a transgenic ungulate by nuclear transfer'
[patent_app_type] => utility
[patent_app_number] => 10/190617
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6832
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190617 | Unactivated ungulate oocytes to produce a transgenic ungulate by nuclear transfer | Jul 8, 2002 | Issued |
Array
(
[id] => 755522
[patent_doc_number] => 07019193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Treatments using transgenic goat produced antithrombin III'
[patent_app_type] => utility
[patent_app_number] => 10/188658
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6514
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/019/07019193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188658 | Treatments using transgenic goat produced antithrombin III | Jul 1, 2002 | Issued |
Array
(
[id] => 1179368
[patent_doc_number] => 06743966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => 'Production of membrane proteins in the milk of transgenic mammals'
[patent_app_type] => B2
[patent_app_number] => 10/185269
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 4690
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185269 | Production of membrane proteins in the milk of transgenic mammals | Jun 26, 2002 | Issued |
| 10/180904 | SPC7 serine protease gene disruptions, and compositions and methods related thereto | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6866542
[patent_doc_number] => 20030192068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Production of recombinant polypeptides by bovine species and transgenic methods'
[patent_app_type] => new
[patent_app_number] => 10/170221
[patent_app_country] => US
[patent_app_date] => 2002-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 31683
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20030192068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10170221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/170221 | Production of recombinant polypeptides by bovine species and transgenic methods | Jun 10, 2002 | Abandoned |
Array
(
[id] => 6261762
[patent_doc_number] => 20020187931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Modulating cell survival by modulating huntingtin function'
[patent_app_type] => new
[patent_app_number] => 10/009478
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16895
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009478 | Modulating cell survival by modulating huntingtin function | May 30, 2002 | Abandoned |
Array
(
[id] => 7275497
[patent_doc_number] => 20040234948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vectors'
[patent_app_type] => new
[patent_app_number] => 10/479912
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16230
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479912
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479912 | Gene transfer into primate embryonic stem cells using VSV-G pseudotyped simian immunodeficiency virus vectors | May 28, 2002 | Issued |
Array
(
[id] => 6745175
[patent_doc_number] => 20030022358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Growth of filterable organisms that require non-diffusable media components'
[patent_app_type] => new
[patent_app_number] => 10/155799
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2578
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155799 | Growth of filterable organisms that require non-diffusable media components | May 23, 2002 | Abandoned |
Array
(
[id] => 7616993
[patent_doc_number] => 06946448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'In utero oral nucleic acid immunization'
[patent_app_type] => utility
[patent_app_number] => 10/155867
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19791
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155867 | In utero oral nucleic acid immunization | May 22, 2002 | Issued |
Array
(
[id] => 6688458
[patent_doc_number] => 20030032183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Stem cell differentiation'
[patent_app_type] => new
[patent_app_number] => 10/156602
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4432
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10156602
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/156602 | Stem cell differentiation | May 22, 2002 | Abandoned |
Array
(
[id] => 6755313
[patent_doc_number] => 20030003090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Directed in vitro differentiation of marrow stromal cells into neural cell progenitors'
[patent_app_type] => new
[patent_app_number] => 10/153972
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6227
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153972 | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors | May 22, 2002 | Abandoned |
Array
(
[id] => 7616993
[patent_doc_number] => 06946448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'In utero oral nucleic acid immunization'
[patent_app_type] => utility
[patent_app_number] => 10/155867
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19791
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155867 | In utero oral nucleic acid immunization | May 22, 2002 | Issued |
Array
(
[id] => 6819228
[patent_doc_number] => 20030070186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Method of cloning animals'
[patent_app_type] => new
[patent_app_number] => 10/155904
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30473
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20030070186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155904 | Method of cloning animals | May 21, 2002 | Abandoned |
| 10/130347 | Method for production of porcine clone embryos via somatic cell nuclear transfer | May 16, 2002 | Abandoned |
Array
(
[id] => 872485
[patent_doc_number] => 07361684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-22
[patent_title] => 'Screening of compounds for treatment of atherosclerosis and heart attack'
[patent_app_type] => utility
[patent_app_number] => 10/147651
[patent_app_country] => US
[patent_app_date] => 2002-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11886
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/361/07361684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147651
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147651 | Screening of compounds for treatment of atherosclerosis and heart attack | May 15, 2002 | Issued |
Array
(
[id] => 6687924
[patent_doc_number] => 20030031649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Gene therapy to promote angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/136545
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10918
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136545 | Gene therapy to promote angiogenesis | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6557962
[patent_doc_number] => 20020194635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Transgenic animals resistant to transmissible spongiform encephalopathies'
[patent_app_type] => new
[patent_app_number] => 10/109551
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16620
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20020194635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109551
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109551 | Transgenic animals resistant to transmissible spongiform encephalopathies | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6554604
[patent_doc_number] => 20020164335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Compositions and methods for the study and diagnosis of prion diseases'
[patent_app_type] => new
[patent_app_number] => 10/106574
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9268
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164335.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106574 | Compositions and methods for the study and diagnosis of prion diseases | Mar 25, 2002 | Abandoned |
Array
(
[id] => 7252579
[patent_doc_number] => 20050074880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Generation of multipotent central nervous system stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/473003
[patent_app_country] => US
[patent_app_date] => 2002-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10127
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473003 | Generation of multipotent central nervous system stem cells | Mar 22, 2002 | Abandoned |
Array
(
[id] => 6817860
[patent_doc_number] => 20030068818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Animal tissue with carbohydrate antigens compatible for human transplantation and a carbohydrate determinant selection system for homologous recombination'
[patent_app_type] => new
[patent_app_number] => 10/105963
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18183
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105963 | Animal tissue with carbohydrate antigens compatible for human transplantation | Mar 20, 2002 | Issued |